Please do not leave this page until complete. This can take a few moments.
Natick-based Boston Scientific Corp. saw improvement over last year in its second quarter, with a net income of $130 million, compared with a loss of $3.6 billion in 2012, the company announced today.
For the period ended June 30, earnings per share were 10 cents, compared to a loss of $2.51 per share during the same time last year.
Last year’s loss was largely due to a goodwill impairment charge of more than $3 billion associated with its Europe, Middle East and Africa reporting unit, which BSX had said was primarily driven by slightly lower projected long-term growth rates due to macroeconomic factors and its performance in the European market.
Sales dipped 1 percent in the second quarter to $1.81 billion from $1.83 billion in 2012 but exceeded the high end of the company’s guidance for the quarter.
The biggest growth area for BSX during the quarter was in Neuromodulation, which saw year over year growth of 21 percent thanks to the launch of BSX’s Precision SpectraTM Spinal Cord Stimulator System to treat chronic pain. Sales were also up 8 percent in Endoscopy, to $325 million, and 5 percent in Peripheral Interventions, to $199 million.
BSX said its continued global expansion led to combined growth of 29 percent in Brazil, Russia, India and China.
“We are pleased with our improved performance during the quarter,” said President and CEO Mike Mahoney. “As we continue to expand our portfolio, our team is inspired to deliver meaningful innovation to more patients globally.”
BSX said it expects sales in the third quarter between $1.7 billion and $1.76 billion with earnings between 3 cents and 5 cents per share.
Full year estimates put sales between $7.05 billion and $7.17 billion with losses between 7 cents and 1 cent per share.
Read more
Competitor Cries Poaching Against BSX In Suit
Boston Scientific Buys Mass. Division Of N.J. Firm
Trial Date Set For BSX Vaginal Mesh Cases
Stay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Sign upWorcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
SubscribeWorcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
See Digital EditionStay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Worcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
Worcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
0 Comments